Bearish flow noted in GSK Pharma with 2,278 puts trading, or 2x expected. Most active are 8/2 weekly 38 puts and 7/12 weekly 33.5 puts, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 2.54, while ATM IV is up nearly 2 points on the day. Earnings are expected on July 31st.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- FDA to evaluate potential risk of neural tube birth defects with dolutegravir
- GSK Acquires Key Vaccine Rights from Partner CureVac in €1.45B Deal
- CureVac jumps 21% to $4.06 after GSK expands licensing deal
- GSK, CureVac restructure existing collaboration into new licensing agreement
- GSK price target raised to $53 from $52.50 at Jefferies